热门资讯> 正文
Atea Pharmaceuticals第一季度裁员约25%
2025-03-27 02:09
- Atea Pharmaceuticals (NASDAQ:AVIR) announced on Wednesday an about 25% reduction in the workforce during the first quarter.
- The layoffs are expected to result in cost savings of ~$15M through 2027.
- Shares were trading 0.78% down as of 1:59 PM ET at $3.18.
More on Atea Pharmaceuticals
- Atea Pharmaceuticals, Inc. (AVIR) Q4 2024 Earnings Call Transcript
- Atea Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on Atea Pharmaceuticals
- Historical earnings data for Atea Pharmaceuticals
- Financial information for Atea Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
